At Bristol Myers Squibb, our employees often ask, “Who are you working for?”—a question that fuels collaboration, accountability, and urgency in our work. Our purpose-driven culture inspires us to discover, develop, and deliver innovative medicines to prevail over serious diseases. We offer uniquely interesting and meaningful work, opportunities for growth, and a supportive environment that values inclusion, wellbeing, flexibility, and comprehensive benefits.
This is work that transforms the lives of patients, and the careers of those who do it.
Position Summary
The Executive Director, GxP Center of Excellence (CoE) reports into VP, R&D Quality. It is a strategic leadership role responsible for establishing and leading an enterprise-wide GxP (GCP, GLP and GVP) quality capability that drives consistent, data driven, risk-ballanced practices and inspection readiness across R&D and associated functions. This role integrates vendor quality, device quality, GxP inspections, CAPA and Investigation Excellence, business development (M&A), governance, QMS, project management, training and knowledge management into a unified CoE operating model.The leader will ensure quality by design, proactive risk management, and regulatory compliance while enabling innovation, speed, and scalable growth across the portfolio.
Through active participation in relevant governance forums, this role oversees the identification, escalation, and mitigation of quality and compliance risks while driving continuous improvement, operational effectiveness, inspection readiness, and quality culture.
The leader champions enterprise-wide quality transformation, leveraging data-driven insights, digital innovation, and cross-functional collaboration to strengthen compliance, enhance organizational capabilities, and enable the efficient delivery of medicines to patients.The leader establishes and evolves the strategic vision, roadmap, and operating model for key quality capabilities with the CoE. Through continuous improvement, digital innovation, and operational excellence, this role builds future-ready capabilities that strengthen compliance, enhance organizational effectiveness, and accelerate the delivery of innovative therapies to patients.
Key Responsibilities
Enterprise GxP CoE Leadership
Define and operationalize the GxP CoE strategy, aligned to enterprise objectives (People, Performance, Pipeline and Innovation).
Establish a centralized capability model that standardizes best practices, tools, and frameworks across R&D Quality.
Provide leadership in embedding proactive, risk-based quality engineering, compliance, and lifecycle management from concept through post-market surveillance, ensuring patient safety, regulatory compliance, and product quality throughout the end-to-end product lifecycle.
Drive a risk-balanced, data-driven quality culture across all GxP domains.
Partner with R&D, Product Development, Regulatory, Medical, Technology, Operations, and Global Quality stakeholders to proactively identify, assess, and mitigate quality and compliance risks across combination products, diagnostics, and digital health technologies.
Drive digital transformation to strengthen compliance, streamline operating model and improve business outcomes
Drive enterprise-wide quality excellence by embedding Quality by Design (QbD), risk-based decision making, lifecycle management, and continuous improvement principles
Champion a right-first-time quality culture and continuous improvement mindset across the enterprise.
Partner with RDQ pillars and relevant stakeholders to assure state of audit and inspection readiness and provide input into audit and inspection strategy and execution
Inspection Management and Readiness
Provide strategic leadership and enterprise oversight for global inspection management and regulatory readiness, ensuring a proactive, risk-based approach to compliance, health authority engagement, and sustained inspection excellence across the R&D portfolio.
Lead the development and execution of global inspection strategies across GCP, GVP, and GLP, including:
Sponsor inspections
Investigator site inspection oversight
Global GLP inspections
Safety surveillance inspections
Pharmacovigilance system inspections
Affiliate and local authority inspections
Post-marketing lifecycle inspections
Regulatory authority engagements (FDA, EMA, PMDA, NMPA, MHRA, and other global agencies)
Establish and maintain a state of continuous inspection readiness through integrated risk assessment, quality intelligence, preparedness programs, and proactive identification of emerging compliance risks.
Oversee inspection response governance, ensuring timely, consistent, and high-quality interactions with regulatory authorities, including inspection preparation, response strategy, and commitment management.
Provide executive oversight of inspection observations, CAPAs, effectiveness evaluations, and systemic remediation efforts to ensure sustainable compliance and continuous improvement.
Partner with senior leaders across Research, Drug Development, Global Quality, and functional teams to drive accountability, strengthen inspection preparedness, and ensure end-to-end ownership of inspection outcomes.
Leverage inspection intelligence, regulatory trends, and cross-industry learnings to identify enterprise risks, inform strategic decisions, and enhance organizational readiness.
Define and advance a future-focused inspection operating model utilizing digital capabilities, advanced analytics, AI-enabled solutions, and innovative approaches to improve efficiency, scalability, and regulatory compliance across the global portfolio
Vendor Quality Oversight
Establish and drive an end-to-end GxP vendor quality oversight framework, including qualification support, quality oversight, performance monitoring, and risk management
Ensure consistent application of GxP expectations across service providers, CROs, CMOs, labs, and strategic partners
Deliver vendor risk segmentation, KPIs/KQIs, and governance mechanisms to proactively mitigate quality risks and improve quality/compliance.
Support and partner across RDQ pillars in inspection readiness and audit readiness for all vendors
Provide leadership to Quality Investigations, Root Cause Analysis (RCA) and CAPA management for internal quality events and oversight of external quality events
Device Quality Integration
- ✓Drive a data-driven, innovative organization that simplifies complexity, accelerates the device, IVD and digital health pipeline, and builds a culture where quality enables speed and fit-for-purpose compliance
- ✓Drive the enterprise quality strategy, governance, and oversight for combination products, diagnostics, and digital health technologies across BMS, partnering with key stakeholders
- ✓Provide strategic quality leadership and oversight for combination products, on-body delivery system (OBDS) platforms etc., ensuring robust design controls, human factors engineering (HFE), risk management, supplier quality, and post-market surveillance throughout the product lifecycle
- ✓Provide leadership in development and execution of quality strategies for in vitro diagnostics (IVD), including oversight of CLIA/CAP laboratory quality systems, assay development and transfer, analytical validation, and diagnostic supplier quality management to ensure regulatory compliance and data integrity
- ✓Represent Quality in governance forums and regulatory interactions, providing strategic guidance on complex quality, compliance, product stewardship, and patient safety matters related to devices, diagnostics, and digital health solutions.
- ✓Continuously monitor evolving industry standards, regulatory expectations (e.g., FDA, EU MDR/IVDR/CDx etc.), and technology trends to develop future-ready quality capabilities that support innovation while maintaining the highest standards of quality, compliance, and patient trust
- ✓Standardize device quality processes, design controls, and lifecycle management practices
Business Development (M&A) Quality
Partner with Global Quality (GQ) and R&D stakeholders to provide input and GxP quality support for Business Development, Licensing, and M&A activities
Define and execute GCP/GLP/GVP due diligence frameworks to assess quality risks, compliance posture, and integration complexity
Provide clear risk assessments and mitigation strategies to inform deal decisions
Provide leadership for post-deal integration of QMS, processes, and governance structures
Create necessary playbook, tools and templates to drive business success and sustainable operating framework
Governance & Quality Risk Management
Establish and maintain robust governance frameworks to ensure consistent oversight, escalation, and decision-making
Act as Operational Lead for R&D Quality Council and support Enterprise Quality Council content generation
Drive and support relevant governance councils including vendor quality councils and Joint Operational councils
Drive cross-functional alignment through quality councils, review boards, and escalation forums
Define clear roles, responsibilities, and accountability across quality and business stakeholders
Ensure transparency through standardized metrics, dashboards, and reporting
Act as the GCP serious breach committee chair and provide leadership to related meetings and decisions
Define relevant KPIs/KQIs as it pertains to assuring state of compliance and continupus improvement
Provide strategic leadership and governance for R&D Quality Risk Management, partnering across RDQ, Global Quality, and Drug Development
Performance trend and signal detection for significant quality events, investigations, serious non-compliance, Serious Breaches, and CAPA management, ensuring timely resolution, sustainable corrective actions, and effective regulatory engagement
Drive continuous improvement of quality systems, risk management frameworks, and governance processes to enhance inspection readiness, compliance performance, and organizational effectiveness across R&D
Quality Management System (QMS) Excellence, Training & Knowledge Management
Provide leadership to the design, implementation, and continuous improvement of a modern, harmonized R&D QMS.
Ensure alignment with global regulatory standards (e.g., Pearl process, ICH E6(R3), GxP regulations etc.)
In partnership with relevant stakeholders, drive simplification, digitization, and scalability of QMS processes
Provide effective management of deviations, CAPAs, change control, and quality events with a focus on root cause and prevention
Establish a future-ready training and capability development strategy aligned to GxP requirements and evolving regulatory expectations
Compliance oversight for R&D role-based training frameworks using relevant KPIs
Implement knowledge management systems to enable reuse of best practices, lessons learned, and inspection insights
Foster a continuous learning culture across R&D teams
CAPA and Investigation Excellence
Provide vision and define the global CAPA strategy and governance model for Research & Development by establishing standard methods, templates, taxonomies, and escalation pathways for quality events, audits/inspections, and significant non-compliances
Design and implement a global CAPA governance framework aligned with regulatory expectations and internal quality standards
Partner with RDQ Global Capability Center Lead, in assuring CAPA-related performance metrics under GCC’s responsibility are effectively managed
Partners with key stakeholders across BMS, including Senior Vice Presidents / Vice Presidents within Research, Drug Development and Quality functions to influence stakeholders, drive accountability and CAPA ownership at all levels
Oversee the identification, documentation, and reporting of serious breaches in compliance with regulatory requirements and company policies, ensuring timely and accurate communication to relevant authorities and stakeholders
Project Management
Lead and drive RDQ strategic projects from initiation through execution, ensuring alignment with BMS/GQ priorities, timelines, budget and measurable outcome
Partner with GQ and R&D business functions to ensure alignment of strategic priorities and delivery to drive corporate goals
Support budget management, tiered management and relevant implementation of lean management principles for RDQ.
People Leadership & Organizational Development
Provides leadership, coaching, and development for direct reports, building organizational capability and cultivating a high-performing team aligned with strategic objectives.
Build team capability through coaching, performance management, and career development planning.
Model and reinforce a culture of quality, accountability, and psychological safety.
Attract and retain top quality talent; resource the TA Quality function appropriately to meet portfolio demands.
Foster a collaborative, cross-functional partnership mindset within the quality team.
Represent BMS at external and cross-industry bodies.
Drive cross-functional collaboration and break down silos across R&D, PDS, and external partners.
Budget Management for team and RDQ when applicable.
Core Competencies
Strategic and enterprise mindset
Risk-based decision-making and critical thinking
Strong governance and execution discipline
Stakeholder influence and executive communication
Innovation and digital/AI-enabled quality transformation
Success Measures
Standardized, scalable GxP CoE operating model established
Demonstrable improvement in quality metrics and inspection outcomes
Effective integration of acquired assets with minimal quality risk
High adoption of training programs and knowledge platforms
Strong engagement and collaboration across global teams
Reduction in repeat quality events and systemic issues
Increased efficiency through standardized and digitized processes
Enhanced vendor and partner performance
Qualification and Requirements Required
Bachelor's or higher degree in a scientific discipline (Life Sciences, Pharmacy, Chemistry, or related field); advanced degree (MS, PhD, PharmD) strongly preferred.
Minimum 15–20 years of progressive pharmaceutical/biotech industry experience, with at least 10 years in Quality roles or equivalent within Development, Regulatory, or Quality Systems contexts.
Deep knowledge of GCP, GVP and other GxPs including understanding of global regulatory frameworks (ICH guidelines, FDA, EMA, MHRA, CFDA, PMDA regulations).
Proven track record leading or managing regulatory authority inspections (FDA, EMA, or equivalent) and responding to inspection observations.
Experience in regulatory activities, including IND/NDA/MAA and post-approval CMC change management.
Demonstrated people leadership experience, including building and developing high-performing quality teams.
Exceptional stakeholder management skills and ability to influence without authority at senior levels.
Strong analytical, communication, and executive presentation skills.
Deep expertise across clinical, device, vendor, and QMS domains
Proven track record in organizational transformation, governance, and global program leadership.
Strong understanding of regulatory expectations and inspection readiness frameworks
Preferred
Experience in a global biopharmaceutical organization with cross-functional matrix leadership.
Familiarity with GxP quality systems (e.g., Veeva Vault QMS, CTMS, eTMF) and quality risk management methodologies (ICH Q9).
Experience in M&A due diligence and integration preferred
Exposure to medical device, diagnostics and novel modalities (gene therapy, cell therapy, biologics, or RNA-based therapies) is a plus.
Key Competencies
Leadership & Strategic Thinking-Technical Quality Expertise
Drives quality vision and strategy
Leads through ambiguity and complexity
Develops and retains talent
Influences senior stakeholders
GxP regulatory knowledge (GCP/GVP/GLP)
Inspection management expertise
Risk-based quality management
CMC and LCM quality oversight
Cross-Functional Partnership-Execution & Results Orientation
Trusted advisor to TA and Medical Affairs leadership
Effective communicator across organizational levels
Collaborative yet decisive
Prioritizes and manages multiple program demands
Delivers quality outcomes on time
Continuous improvement mindset
#LI- Hybrid
We hire for skills and capabilities, not just credentials – if this role excites you, but doesn’t perfectly match your resume, we encourage you to apply anyway.
Compensation Overview
$260,860 - $316,097
The starting pay range(s) listed above is for full-time employees (FTE). You may also be eligible for additional discretionary incentive cash and stock opportunities. We determine starting pay thoughtfully – carefully considering the nature of the role, required skills, work location, schedule and the knowledge and experience you bring.
Final compensation is guided by pay equity principles and applicable employment laws. Compensation programs are reviewed on an ongoing basis and may be adjusted over time to reflect evolving market factors, and individual, team or Company performance.
Benefits
Subject to the terms and conditions of the applicable plans then in effect, you may be eligible to participate in our comprehensive benefit plans – including wellbeing support, retirement and financial protection benefits, and insurance offerings (medical, dental, vision, life and disability).
U.S.-based exempt employees are eligible for Flexible Time Off (FTO), which provides paid time off without a set accrual limit, subject to manager approval, along with 11 paid company holidays each year.
Non-exempt employees, RayzeBio employees, and employees located in Puerto Rico receive 160 hours of paid vacation annually for new hires (subject to manager approval), 11 paid company holidays, and 3 optional holidays.
Depending on eligibility, employees may also have access to additional time-off benefits, including paid sick leave, up to two paid volunteer days per year, summer hours flexibility, and leaves of absence for medical, personal, parental, caregiver, bereavement, or military needs. Eligible employees also enjoy an annual Global Shutdown between Christmas Day and New Year's Day.
U.S.-based job seekers can explore full benefit offerings at https://careers.bms.com/benefits
How We Work
Where you work matters – because collaboration, innovation and patient impact happen in many settings. Our roles are structured across four work models: site-essential, site-by-design, field-based and remote-by-design. The model assigned to this role is based on its core responsibilities. Learn more at https://careers.bms.com/ways-of-working.
Supporting People with Disabilities
BMS is dedicated to ensuring that people with disabilities can excel through a transparent recruitment process, reasonable workplace accommodations/adjustments and ongoing support in their roles. Applicants can request a reasonable workplace accommodation/adjustment prior to accepting a job offer. If you require reasonable accommodations/adjustments in completing this application, or in any part of the recruitment process, direct your inquiries to adastaffingsupport@bms.com.
Visit careers.bms.com/eeo-accessibility to access our complete Equal Employment Opportunity statement.
Candidate Rights
BMS will consider qualified applicants with arrest and conviction records, pursuant to applicable laws in your area.
For roles based in Los Angeles County only: If you live in or expect to work from Los Angeles County if hired for this position, please visit this page for important additional information: https://careers.bms.com/california-residents/
Data Protection
We will never request payments, financial information, or social security numbers during our application or recruitment process. Learn more about protecting yourself at https://careers.bms.com/fraud-protection.
Any data processed in connection with role applications will be treated in accordance with applicable data privacy policies and regulations.
If this posting is missing required information required by local law or incorrect, contact BMS at TAEnablement@bms.com with the Job Title and Requisition number. Do not send application-related inquiries to this email. To check your application status, please login to your Candidate Home Account.
R1606416 : Executive Director, GxP Quality Center of Excellence